UK Antitrust Watchdog Hits GSK With Pay-For-Delay Claims
A U.K. antitrust regulator slammed GlaxoSmithKline PLC with an antitrust complaint Friday alleging the pharmaceutical giant entered pay-for-delay deals with three generic-drug makers to preserve its hold on the market for...To view the full article, register now.
Already a subscriber? Click here to view full article